Jecure Therapeutics' Series A Round

Jecure Therapeutics raised a round of funding on February 15, 2017. Investors include Versant Ventures.

Jecure Therapeutics focuses on the discovery of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis.…

Articles about Jecure Therapeutics' Series A Round: